Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Marvin S. Swartz, MD
JCP
Original Research
Heterogeneity of Treatment Effects of LAI Antipsychotics
November 27, 2018
Which subgroups of patients with schizophrenia or schizoaffective disorder may be prone to treatment failure? Is it men or women, old or young, or are more factors involved? Researchers...
T. Scott Stroup
,
Natalie A. Bareis
,
Robert A. Rosenheck
, et al
JCP
Original Research
Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia
September 21, 2010
Donald E. Addington
,
Somaia Mohamed
,
Robert A. Rosenheck
, et al
JCP
Original Research
Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia
August 10, 2010
Stanley N. Caroff
,
Vicki G. Davis
,
Del D. Miller
, et al
JCP
Original Research
Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care
March 15, 2006
Haya Ascher-Svanum
,
Douglas E. Faries
,
Baojin Zhu
, et al
JCP
Original Research
Reducing Violence Risk in Persons With Schizophrenia: Olanzapine Versus Risperidone
December 15, 2004
Jeffrey W. Swanson
,
Marvin S. Swartz
,
Eric B. Elbogen
, et al
